Bayer bags access to delivery tech behind Pfizer’s Comirnaty – Fierce Biotech
The deal allows Bayer to use Acuitas Therapeutics’ lipid nanoparticle delivery technology to get its in vivo gene editing candidates to the liver. Read source
Click to rate this post!
[Total: 0 Average: 0]